TuHURA Biosciences (HURA) Total Current Liabilities (2012 - 2026)

TuHURA Biosciences' Total Current Liabilities history runs 15 years deep, the most recent figure standing at $6.1 million for Q1 2026.

• On a quarterly basis, Total Current Liabilities rose 26.86% year-over-year to $6.1 million in Q1 2026; TTM through Mar 2026 was $6.1 million, a 26.86% increase from a year earlier, with the FY2025 full-year figure at $5.9 million, up 11.06% from the prior year.
• Total Current Liabilities improved to $6.1 million in Q1 2026 per HURA's latest filing, from $5.9 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $15.2 million in Q2 2025 and bottomed at $1.3 million in Q1 2024.
• The 5-year median for Total Current Liabilities is $3.5 million (2022), against an average of $4.6 million.
• Across the five-year window, Total Current Liabilities plunged 51.94% in 2024 and soared 571.61% in 2025, its largest moves.
• Year by year, Total Current Liabilities stood at $3.2 million in 2022, then rose by 11.03% to $3.6 million in 2023, then surged by 48.2% to $5.3 million in 2024, then increased by 11.06% to $5.9 million in 2025, then climbed by 2.49% to $6.1 million in 2026.
• Per Business Quant, the three latest HURA Total Current Liabilities figures stand at $6.1 million (Q1 2026), $5.9 million (Q4 2025), and $8.8 million (Q3 2025).